Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2019; Volume 39,Issue 2

Reviews

  • You have access
    MicroRNA-based Targeted Therapeutics in Pancreatic Cancer
    NILGUN GURBUZ and BULENT OZPOLAT
    Anticancer Research February 2019, 39 (2) 529-532; DOI: https://doi.org/10.21873/anticanres.13144
  • You have access
    The Role of KRAS in Endometrial Cancer: A Mini-Review
    MICHAIL SIDERIS, ELIF ILIRIA EMIN, ZIENA ABDULLAH, JOHN HANRAHAN, KONSTANTINA MARIA STEFATOU, VASILEIOS SEVAS, ECE EMIN, TONY HOLLINGWORTH, FUNLAYO ODEJINMI, SAVVAS PAPAGRIGORIADIS, SOTIRIS VIMPLIS and FREDRIC WILLMOTT
    Anticancer Research February 2019, 39 (2) 533-539; DOI: https://doi.org/10.21873/anticanres.13145
  • You have access
    Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
    NITHIKOON AKSORN and PITHI CHANVORACHOTE
    Anticancer Research February 2019, 39 (2) 541-548; DOI: https://doi.org/10.21873/anticanres.13146

Experimental Studies

  • You have access
    A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer
    TOSHIYUKI SEKI, JIANYUN LIU, RANDY R. BRUTKIEWICZ and MORIYA TSUJI
    Anticancer Research February 2019, 39 (2) 549-555; DOI: https://doi.org/10.21873/anticanres.13147
  • You have access
    High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma
    KOTARO HAGIO, SHINJI FURUYA, JIRO NAKAMURA, SUGURU MARUYAMA, KENSUKE SHIRAISHI, HIROKI SHIMIZU, HIDENORI AKAIKE, NAOHIRO HOSOMURA, YOSHIHIKO KAWAGUCHI, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAISUKE ICHIKAWA
    Anticancer Research February 2019, 39 (2) 557-565; DOI: https://doi.org/10.21873/anticanres.13148
  • You have access
    Association of CD31 and p53 With Survival of Ovarian Cancer Patients
    LENE RASK, CLAUS K. HØGDALL, SUSANNE K. KJAER, LISE CHRISTENSEN, ALLAN JENSEN, JAN BLAAKAER, IB JARLE CHRISTENSEN and ESTRID V.S. HØGDALL
    Anticancer Research February 2019, 39 (2) 567-576; DOI: https://doi.org/10.21873/anticanres.13149
  • You have access
    Oligodendrocytes Up-regulate the Invasive Activity of Glioblastoma Cells via the Angiopoietin-2 Signaling Pathway
    TOSHIYUKI KAWASHIMA, MASAKAZU YASHIRO, HIROAKI KASASHIMA, YUZO TERAKAWA, TAKEHIRO UDA, KOSUKE NAKAJO, RYOKO UMABA, YUTA TANOUE, SAMANTHA TAMRAKAR and KENJI OHATA
    Anticancer Research February 2019, 39 (2) 577-584; DOI: https://doi.org/10.21873/anticanres.13150
  • You have access
    Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer
    ANNE M. AHTIKOSKI, JUHA KANGAS, RIIKKA SALONEN, ULLA PUISTOLA and PEETER KARIHTALA
    Anticancer Research February 2019, 39 (2) 585-590; DOI: https://doi.org/10.21873/anticanres.13151
  • You have access
    Isothiocyanate-induced Cell Cycle Arrest in a Novel In Vitro Exposure Protocol of Human Malignant Melanoma (A375) Cells
    THEODORA MANTSO, IOANNIS ANESTOPOULOS, ELEFTHERIA LAMPRIANIDOU, IOANNIS KOTSIANIDIS, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS
    Anticancer Research February 2019, 39 (2) 591-596; DOI: https://doi.org/10.21873/anticanres.13152
  • You have access
    Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma
    DAISUKE SAKAMOTO, TOSHINORI TAKAGI, MITSUGU FUJITA, SEIICHI OMURA, YASUNORI YOSHIDA, TOMOKO IIDA and SHINICHI YOSHIMURA
    Anticancer Research February 2019, 39 (2) 597-607; DOI: https://doi.org/10.21873/anticanres.13153
  • You have access
    AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1
    MASAHIRO YAMAMOTO, SHUHEI SUZUKI, KEITA TOGASHI, TOMOMI SANOMACHI, SHIZUKA SEINO, CHIFUMI KITANAKA and MASASHI OKADA
    Anticancer Research February 2019, 39 (2) 609-617; DOI: https://doi.org/10.21873/anticanres.13154
  • You have access
    Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of 18FDG PET-CT
    MAXIME LEGROS, FRANÇOIS MARGUERITTE, ANTOINE TARDIEU, ELISE DELUCHE, VALERE BELLE MBOU, AYMELINE LACORRE, ALEXANDRU CEUCA, YVES AUBARD, JACQUES MONTEIL, CAMILLE SALLEE and TRISTAN GAUTHIER
    Anticancer Research February 2019, 39 (2) 619-625; DOI: https://doi.org/10.21873/anticanres.13155
  • You have access
    Tenascin XB Is a Novel Diagnostic Marker for Malignant Mesothelioma
    KOJI NAKAYAMA, MASAHIRO SEIKE, RINTARO NORO, SUSUMU TAKEUCHI, KUNIKO MATSUDA, SHINOBU KUNUGI, KAORU KUBOTA and AKIHIKO GEMMA
    Anticancer Research February 2019, 39 (2) 627-633; DOI: https://doi.org/10.21873/anticanres.13156
  • You have access
    Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10
    ARISA KUMAGAI-TOGASHI, HIROSHI UOZAKI, YOSHINAO KIKUCHI, SHIORI WATABE, SATOE NUMAKURA and MASATO WATANABE
    Anticancer Research February 2019, 39 (2) 635-640; DOI: https://doi.org/10.21873/anticanres.13157
  • You have access
    Survival Probabilities Related to Histology, Grade and Stage in Patients With Salivary Gland Tumors
    YAIR ISRAEL, ADI RACHMIEL, KONSTANTIN GOUREVICH and RAFAEL NAGLER
    Anticancer Research February 2019, 39 (2) 641-647; DOI: https://doi.org/10.21873/anticanres.13158
  • You have access
    Chloroquine Enhances Rapamycin-induced Apoptosis in MG63 Cells
    YOICHI ISHIBASHI, OSAMU NAKAMURA, YOSHIKI YAMAGAMI, HIDEKI NISHIMURA, NATSUKO FUKUOKA and TETSUJI YAMAMOTO
    Anticancer Research February 2019, 39 (2) 649-654; DOI: https://doi.org/10.21873/anticanres.13159
  • You have access
    Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response
    SIDIKA ÖZTOP, AYNUR IŞIK, GÜNEŞ GÜNER, HAKAN GÜRDAL, ERDEM KARABULUT, ERKAN YILMAZ and AYTEKİN AKYOL
    Anticancer Research February 2019, 39 (2) 655-662; DOI: https://doi.org/10.21873/anticanres.13160
  • You have access
    Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer
    GO EUN BAE, SUNG-IM DO, KYUNGEUN KIM, JI HYUN PARK, SIHYUN CHO and HYUN-SOO KIM
    Anticancer Research February 2019, 39 (2) 663-670; DOI: https://doi.org/10.21873/anticanres.13161
  • You have access
    Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    NAOKI KUBO, TAISHI HARADA, YOSHIMASA SHIRAISHI, KANAME NOSAKI, NORIAKI NAKAGAKI, MASAFUMI TAKESHITA, HIROSHI OUCHI, EIJI IWAMA, KENTARO TANAKA, ISAMU OKAMOTO, HIROYUKI SASAKI and YOICHI NAKANISHI
    Anticancer Research February 2019, 39 (2) 671-677; DOI: https://doi.org/10.21873/anticanres.13162
  • You have access
    Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe
    WOJCIECH TRYBUS, TEODORA KRÓL, EWA TRYBUS, ANNA STACHURSKA, GRZEGORZ KRÓL and ANNA KOPACZ-BEDNARSKA
    Anticancer Research February 2019, 39 (2) 679-686; DOI: https://doi.org/10.21873/anticanres.13163
  • You have access
    Apoptosis Induced by Ultraviolet A Exposure in the Presence of Enoxacin in HL-60 Cells
    HARUKA SHINADA, TAKAHIRO WATANABE, KAZUHO OKUDAIRA, YUMIKO IWASE, KOJI NISHI and NAGAHIKO YUMITA
    Anticancer Research February 2019, 39 (2) 687-693; DOI: https://doi.org/10.21873/anticanres.13164
  • You have access
    Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib
    CHING-TING WEI, LEI-CHIN CHEN, YI-PING HSIANG, YUNG-JUN HUNG, PEI-HSUAN CHIEN, HSIAO-LIN PAN and YUN-JU CHEN
    Anticancer Research February 2019, 39 (2) 695-701; DOI: https://doi.org/10.21873/anticanres.13165
  • You have access
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer
    YOSHITO KUSUHARA, KEI DAIZUMOTO, KAICHI KAWAI, KENTO HIRAYAMA, MINORU KOWADA, TERUMICHI SHINTANI, YAYOI FUKUHARA, TSOGT-OCHIR DONDOO, KEISUKE OZAKI, MEGUMI TSUDA, TOMOYA FUKAWA, HIROYOSHI NAKATSUJI, YOSHIMI BANDO, HISANORI UEHARA, TOMOHARU FUKUMORI, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA
    Anticancer Research February 2019, 39 (2) 703-711; DOI: https://doi.org/10.21873/anticanres.13166
  • You have access
    CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An In Vitro Study
    TZONG-SHYUAN TAI, PAI-MEI LIN, CHING-FANG WU, SHIH-KAI HUNG, CHUNG-I HUANG, CHIH-CHUN WANG and YU-CHIEH SU
    Anticancer Research February 2019, 39 (2) 713-720; DOI: https://doi.org/10.21873/anticanres.13167
  • You have access
    The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells
    JHEN-YU CHEN, WEI-CHIEN HUANG, CHING-TING WEI, PEI-HSUAN CHIEN and YUN-JU CHEN
    Anticancer Research February 2019, 39 (2) 721-726; DOI: https://doi.org/10.21873/anticanres.13168
  • You have access
    Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells
    KAMILA ŚRODA-POMIANEK, KRYSTYNA MICHALAK, ANNA PALKO-ŁABUZ, ANNA URYGA, BERENIKA SZCZĘŚNIAK-SIĘGA and OLGA WESOŁOWSKA
    Anticancer Research February 2019, 39 (2) 727-734; DOI: https://doi.org/10.21873/anticanres.13169
  • You have access
    Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling: In Vitro Evaluation on VEGFR2-positive Cell Lines
    JIRI JANOUSEK, PAVEL BARTA, ZBYNEK NOVY, KATERINA ZILKOVA and FRANTISEK TREJTNAR
    Anticancer Research February 2019, 39 (2) 735-744; DOI: https://doi.org/10.21873/anticanres.13170
  • You have access
    Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential
    TOMASZ KOSTRZEWA, PAULINA PRZYCHODZEN, MAGDALENA GORSKA-PONIKOWSKA and ALICJA KUBAN-JANKOWSKA
    Anticancer Research February 2019, 39 (2) 745-749; DOI: https://doi.org/10.21873/anticanres.13171
  • You have access
    Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
    SOO JUNG LEE, JAE-HWAN JEONG, IN HEE LEE, JEEYEON LEE, JIN HYANG JUNG, HO YONG PARK, DUK HEE LEE and YEE SOO CHAE
    Anticancer Research February 2019, 39 (2) 751-758; DOI: https://doi.org/10.21873/anticanres.13172
  • You have access
    Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-inhibiting Phthalimido-Alkanamide Derivative
    CHAN WOO WEE, JIN HO KIM, HAK JAE KIM, HYUN-CHEOL KANG, SOO YOUN SUH, BEOM SOO SHIN, EUNSOOK MA and IL HAN KIM
    Anticancer Research February 2019, 39 (2) 759-769; DOI: https://doi.org/10.21873/anticanres.13173
  • You have access
    Effect of Radiation on the Expression of CVD-related miRNAs, Inflammation and Endothelial Dysfunction of HUVECs
    ROSER ESPLUGAS, MONTSERRAT BELLÉS, NOEMÍ SERRA, MERITXELL ARENAS, VÍCTOR HERNÁNDEZ, JOAN CARLES VALLVÉ and VICTORIA LINARES
    Anticancer Research February 2019, 39 (2) 771-780; DOI: https://doi.org/10.21873/anticanres.13174

Clinical Studies

  • You have access
    Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution
    AMMAR SUKARI, MISAKO NAGASAKA, ROBA ALHASAN, DHAVAL PATEL, ANTOINETTE WOZNIAK, RADHAKRISHNAN RAMCHANDREN, ULKA VAISHAMPAYAN, AMY WEISE, LAWRENCE FLAHERTY, HYEJEONG JANG, SEONGHO KIM and SHIRISH GADGEEL
    Anticancer Research February 2019, 39 (2) 781-790; DOI: https://doi.org/10.21873/anticanres.13175
  • You have access
    No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012
    JONAS NILSSON, JACOB JÄRÅS, ROGER HENRIKSSON, GEORG HOLGERSSON, STEFAN BERGSTRÖM, JIMMY ESTENBERG, TORSTEN AUGUSTSSON and MICHAEL BERGQVIST
    Anticancer Research February 2019, 39 (2) 791-796; DOI: https://doi.org/10.21873/anticanres.13176
  • You have access
    Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA Trial
    AMIR SONNENBLICK, ANDREW BAILEY, BEATRICE UZIELY, MICHAEL UNTCH, IAN SMITH, LUCA GIANNI, JOSE BASELGA, CHRISTIAN JACKISCH, DAVID CAMERON, RICHARD BELL, DIMITRIOS ZARDAVAS, NEDAL AL-SAKAFF, RICHARD D. GELBER, MITCH DOWSETT, BRIAN LEYLAND-JONES, MARTINE J. PICCART-GEBHART and EVANDRO DE AZAMBUJA
    Anticancer Research February 2019, 39 (2) 797-802; DOI: https://doi.org/10.21873/anticanres.13177
  • You have access
    Patterns of Care in Pediatric Craniopharyngioma: Outcomes Following Definitive Radiotherapy
    TANNER K. HILL, MICHAEL J. BAINE, VIVEK VERMA, MORSHED ALAM, ELIZABETH R. LYDEN, CHI LIN, EILEEN P. CONNOLLY and CHI ZHANG
    Anticancer Research February 2019, 39 (2) 803-807; DOI: https://doi.org/10.21873/anticanres.13178
  • You have access
    Nitrotyrosine (NT), a Nitrosative Stress Biomarker, Plasma Concentrations in Gallstone Disease and Cancer Patients
    IINA SAIMANEN, DINA RAHKOLA, VIIVI KUOSMANEN, JARI KÄRKKÄINEN, TUOMAS SELANDER, ANU HOLOPAINEN, SAMULI ASPINEN and MATTI ESKELINEN
    Anticancer Research February 2019, 39 (2) 809-814; DOI: https://doi.org/10.21873/anticanres.13179
  • You have access
    Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
    MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA
    Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
  • You have access
    Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1
    JULIANE MEHLAN, FRANK SCHÜTTAUF, JOHANNES M. SALAMON, UWE KORDES, REINHARD E. FRIEDRICH and VICTOR-FELIX MAUTNER
    Anticancer Research February 2019, 39 (2) 827-831; DOI: https://doi.org/10.21873/anticanres.13181
  • You have access
    Crypts With Corrupted Shapes in Non-polypoid Adenomas
    CARLOS A. RUBIO and PETER T. SCHMIDT
    Anticancer Research February 2019, 39 (2) 833-838; DOI: https://doi.org/10.21873/anticanres.13182
  • You have access
    Malignant Peritoneal Mesothelioma: Treatment Options and Survival
    SILJA A.S. SALO, ILKKA ILONEN, SANNA LAAKSONEN, MARJUKKA MYLLÄRNIEMI, JARMO A. SALO and TUOMO RANTANEN
    Anticancer Research February 2019, 39 (2) 839-845; DOI: https://doi.org/10.21873/anticanres.13183
  • You have access
    Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature
    MARIA A. SMOLLE, KARL KASHOFER, JAKOB M. RIEDL, MICHAEL STOTZ and ARMIN GERGER
    Anticancer Research February 2019, 39 (2) 847-852; DOI: https://doi.org/10.21873/anticanres.13184
  • You have access
    The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial
    AMAR M. ELTWERI, ANNE L. THOMAS, WEN Y. CHUNG, BRUNO MORGAN, JOHN THOMPSON, ASHLEY R. DENNISON and DAVID J. BOWREY
    Anticancer Research February 2019, 39 (2) 853-861; DOI: https://doi.org/10.21873/anticanres.13185
  • You have access
    Age Adjusted Charlson Comorbidity Index Strongly Influences Survival, Irrespective of Performance Status and Age, in Patients With Advanced Prostatic Cancer Treated With Enzalutamide
    HENDRIK KAREL VAN HALTEREN and GERARD VREUGDENHIL
    Anticancer Research February 2019, 39 (2) 863-866; DOI: https://doi.org/10.21873/anticanres.13186
  • You have access
    Validation and Verification of Three-dimensional Systems in Laparoscopic Distal Pancreatectomy
    EUNSUNG JUN, ABDULWAHAB A. ALSHAHRANI, KI BYUNG SONG, DAE WOOK HWANG, JAE HOON LEE, SANG HYUN SHIN, YOUNG-JOO LEE and SONG CHEOL KIM
    Anticancer Research February 2019, 39 (2) 867-874; DOI: https://doi.org/10.21873/anticanres.13187
  • You have access
    Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study
    WOLFGANG SCHULTZE-SEEMANN, HOLGER SCHULZ, BARBARA TSCHECHNE and MANUEL HÄCKL
    Anticancer Research February 2019, 39 (2) 875-882; DOI: https://doi.org/10.21873/anticanres.13188
  • You have access
    Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein
    TAKANOBU YAMAO, YO-ICHI YAMASHITA, KATSUNORI IMAI, NAOKI UMEZAKI, MASAYO TSUKAMOTO, YUKI KITANO, KOTA ARIMA, TATSUNORI MIYATA, SHIGEKI NAKAGAWA, HIROHISA OKABE, HIROMITSU HAYASHI, AKIRA CHIKAMOTO, TAKATOSHI ISHIKO and HIDEO BABA
    Anticancer Research February 2019, 39 (2) 883-889; DOI: https://doi.org/10.21873/anticanres.13189
  • You have access
    Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer
    TAKASHI UNO, AKI KANAZAWA, MIHO WATANABE NEMOTO, RINTARO HARADA, HIROKI KOBAYASHI, MAKOTO SAITO, YUMA IWAI, HIROKAZU USUI, AKIRA MITSUHASHI and MAKIO SHOZU
    Anticancer Research February 2019, 39 (2) 891-895; DOI: https://doi.org/10.21873/anticanres.13190
  • You have access
    Neoadjuvant Tyrosine Kinase Inhibition in Locally-advanced Non-small Cell Lung Cancer: Two Cases and a Brief Literature Review
    ANISH B. PARIKH, LINDSAY HAMMONS and JORGE E. GOMEZ
    Anticancer Research February 2019, 39 (2) 897-902; DOI: https://doi.org/10.21873/anticanres.13191
  • You have access
    Neuroendocrine Tumor of the Hilar Bile Duct
    NAOKI UMEZAKI, DAISUKE HASHIMOTO, YO-ICHI YAMASHITA, SHIGEKI NAKAGAWA, YOUSUKE NAKAO, RUMI ITOYAMA, TOSHIHIKO YUSA, TAKANOBU YAMAO, HIROHISA OKABE, KATSUNORI IMAI, HIROMITSU HAYASHI, AKIRA CHIKAMOTO and HIDEO BABA
    Anticancer Research February 2019, 39 (2) 903-907; DOI: https://doi.org/10.21873/anticanres.13192
  • You have access
    Carbon Ion Radiotherapy in the Management of the Tumors of the Peripheral Nervous System
    VIVIANA VITOLO, MARIA ROSARIA FIORE, AMELIA BARCELLINI, BARBARA VISCHIONI, ALBERTO IANNALFI, ANGELICA FACOETTI, PIERO FOSSATI, MARIA BONORA, SARA RONCHI, EMMA D'IPPOLITO, RACHELE PETRUCCI, GISELA VISELNER, MARIO CIOCCA, LORENZO PREDA, FRANCESCA VALVO and ROBERTO ORECCHIA
    Anticancer Research February 2019, 39 (2) 909-913; DOI: https://doi.org/10.21873/anticanres.13193
  • You have access
    Diagnostic Utility of Third-Look, Contrast-Enhanced Sonography Followed by Needle Biopsy for MRI, But Not Second-look Ultrasonography-detected Breast Lesions
    TOMOHIRO MIYAKE, SEUNG JIN KIM, MASAFUMI SHIMODA, NAOFUMI KAGARA, TOMONORI TANEI, YASUTO NAOI, KENZO SHIMAZU and SHINZABURO NOGUCHI
    Anticancer Research February 2019, 39 (2) 915-921; DOI: https://doi.org/10.21873/anticanres.13194
  • You have access
    Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
    KOICHI SARUWATARI, TOKUNORI IKEDA, SHO SAEKI, NAOKI SHINGU, KOSUKE IMAMURA, TAIYOU KOMATU, SUNAO USHIJIMA, HIROTAKA MARUYAMA, KOSUKE KASHIWABARA, YUSUKE TOMITA, HIDENORI ICHIYASU, KAZUHIKO FUJII and TAKURO SAKAGAMI
    Anticancer Research February 2019, 39 (2) 923-931; DOI: https://doi.org/10.21873/anticanres.13195
  • You have access
    Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy
    HIROFUMI MATSUOKA, KEIICHIRO NAKAMURA, YUKO MATSUBARA, NAOYUKI IDA, TAKESHI NISHIDA, CHIKAKO OGAWA, KUNIAKI KATSI, SUSUMU KANAZAWA and HISASHI MASUYAMA
    Anticancer Research February 2019, 39 (2) 933-939; DOI: https://doi.org/10.21873/anticanres.13196
  • You have access
    Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma
    AKIRA WATANABE, NORIHUMI HARIMOTO, KENICHIRO ARAKI, NORIO KUBO, TAKAMICHI IGARASHI, MARIKO TSUKAGOSHI, NORIHIRO ISHII, TAKAHIRO YAMANAKA, TOMOHARU YOSHIZUMI and KEN SHIRABE
    Anticancer Research February 2019, 39 (2) 941-947; DOI: https://doi.org/10.21873/anticanres.13197
  • You have access
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer
    MU LI, SOPHI GU, RUI MAO, YING NING, NITIN TRIVEDI, AHMAD SIDDIQUI, PENGYANG LI and LIHONG HUO
    Anticancer Research February 2019, 39 (2) 949-956; DOI: https://doi.org/10.21873/anticanres.13198
  • You have access
    Low-molecular-weight Protein Tyrosine Phosphatase Is a Possible Biomarker for Predicting Postoperative Biochemical Recurrence in Prostate Cancer With Negative Surgical Margins
    HIROFUMI KUROSE, KOSUKE UEDA, REIICHIRO KONDO, SACHIKO OGASAWARA, HIRONORI KUSANO, SAKIKO SANADA, YOSHIKI NAITO, JUN AKIBA, TATSUYUKI KAKUMA, TSUKASA IGAWA and HIROHISA YANO
    Anticancer Research February 2019, 39 (2) 957-964; DOI: https://doi.org/10.21873/anticanres.13199
  • You have access
    Impact of Repeated Hepatectomy on Liver Regeneration in Hepatocellular Carcinoma: A Propensity Score-based Analysis
    KOTA ARIMA, HIDETOSHI NITTA, TORU BEPPU, SHIGEKI NAKAGAWA, HIROHISA OKABE, KATSUNORI IMAI, AKIRA CHIKAMOTO, YO-ICHI YAMASHITA, YASUYUKI YAMASHITA and HIDEO BABA
    Anticancer Research February 2019, 39 (2) 965-970; DOI: https://doi.org/10.21873/anticanres.13200
  • You have access
    Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma
    NORIFUMI HARIMOTO, KOUKI HOSHINO, RYO MURANUSHI, KEI HAGIWARA, TAKAHIRO YAMANAKA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, HIROSHI TANAKA, AKIRA WATANABE, NORIO KUBO, KENICHIROU ARAKI, HIROYASU TOMONAGA, TETSUYA HIGUCHI, YOSHITO TSUSHIMA and KEN SHIRABE
    Anticancer Research February 2019, 39 (2) 971-977; DOI: https://doi.org/10.21873/anticanres.13201
  • You have access
    Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome
    SHINICHI ASAKA, TAKESHI SHIMAKAWA, KENTARO YAMAGUCHI, TAKAO KATSUBE, TAKEBUMI USUI, HAJIME YOKOMIZO, SHUNICHI SHIOZAWA and YOSHIHIKO NARITAKA
    Anticancer Research February 2019, 39 (2) 979-985; DOI: https://doi.org/10.21873/anticanres.13202
  • You have access
    Adverse Effects of Preoperative Sarcopenia on Postoperative Complications of Patients With Gastric Cancer
    TATSURO TAMURA, KATSUNOBU SAKURAI, MIKIO NAMBARA, YUICHIRO MIKI, TAKAHIRO TOYOKAWA, NAOSHI KUBO, HIROAKI TANAKA, KAZUYA MUGURUMA, MASAKAZU YASHIRO and MASAICHI OHIRA
    Anticancer Research February 2019, 39 (2) 987-992; DOI: https://doi.org/10.21873/anticanres.13203
  • You have access
    Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer
    DONGHA LEE, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, MASASHI YAMAMOTO, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI, TAKUMI FUKUMOTO and YOSHIHIRO KAKEJI
    Anticancer Research February 2019, 39 (2) 993-998; DOI: https://doi.org/10.21873/anticanres.13204
  • You have access
    Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
    MAKI TODO, SUGURU SHIROTAKE, KOSHIRO NISHIMOTO, YOTA YASUMIZU, GOU KANEKO, HIDEYUKI KONDO, TAKASHI OKABE, HIDEKI MAKABE and MASAFUMI OYAMA
    Anticancer Research February 2019, 39 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.13205
  • You have access
    Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer
    SANG HYUN SHIN, YEJONG PARK, DAE WOOK HWANG, KI BYUNG SONG, JAE HOON LEE, JAEWOO KWON, CHANGHOON YOO, SHADI ALSHAMMARY and SONG CHEOL KIM
    Anticancer Research February 2019, 39 (2) 1005-1012; DOI: https://doi.org/10.21873/anticanres.13206
  • You have access
    Use of a Reinforced Triple-row Stapler Following Distal Pancreatectomy Reduces the Incidence of Postoperative Pancreatic Fistula in Patients With a High BMI
    HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, NAOHIRO HOSOMURA, RYO SAITO, KAZUNORI TAKAHASHI, ATSUSHI YAMAMOTO, MITSUAKI WATANABE, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, MASANORI MATUSDA, JUN ITAKURA, HIDEKI FUJII and DAISUKE ICHIKAWA
    Anticancer Research February 2019, 39 (2) 1013-1018; DOI: https://doi.org/10.21873/anticanres.13207
  • You have access
    Gastric Lavage Malignant Cells (yGL) and Hypohemoglobinemia (yAnemia) as New Systems of Tumor Regression Grading and Prognostic Prediction for Gastric Cancer After Neoadjuvant Treatment
    EDOARDO VIRGILIO, ENRICO GIARNIERI, MARIA ROSARIA GIOVAGNOLI, MONICA MONTAGNINI, ANTONELLA PROIETTI, ROSARIA D'URSO, ALESSANDRA FEGIZ, PAOLO MERCANTINI, GENOVEFFA BALDUCCI and MARCO CAVALLINI
    Anticancer Research February 2019, 39 (2) 1019-1027; DOI: https://doi.org/10.21873/anticanres.13208
  • You have access
    Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer
    MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA
    Anticancer Research February 2019, 39 (2) 1029-1034; DOI: https://doi.org/10.21873/anticanres.13209
  • You have access
    Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients
    DIDIER AUTRAN, MARYLINE BARRIE, MONA MATTA, COLETTE MONSERRAT, CHANTAL CAMPELLO, GREGORIO PETRIRENA, CELINE BOUCARD, LAETITIA PADOVANI, ANDERSON LOUNDOU, ROMAIN APPAY, THOMAS GRAILLON, HENRY DUFOUR, DOMINIQUE FIGARELLA-BRANGER, OLIVIER CHINOT and EMELINE TABOURET
    Anticancer Research February 2019, 39 (2) 1035-1041; DOI: https://doi.org/10.21873/anticanres.13210
  • You have access
    Uptake of 18F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage
    HIDENORI SUZUKI, TSUNEO TAMAKI, MASAMI NISHIO, HOSHINO TERADA, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and NOBUHIRO HANAI
    Anticancer Research February 2019, 39 (2) 1043-1049; DOI: https://doi.org/10.21873/anticanres.13211
  • You have access
    Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy
    MASATSUNE SHIBUTANI, HISASHI NAGAHARA, TATSUNARI FUKUOKA, YASUHITO ISEKI, SHINJI MATSUTANI, EN WANG, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research February 2019, 39 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.13212
  • You have access
    Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202
    SHUNJI ENDO, YUKINORI KUROKAWA, MAKIO GAMOH, YUTAKA KIMURA, JIN MATSUYAMA, HIROKAZU TANIGUCHI, ATSUSHI TAKENO, RYOHEI KAWABATA, JUNJI KAWADA, TORU MASUZAWA, KAZUYOSHI YAMAMOTO, KOUJI KOBAYASHI, DAISUKE SAKAI, TOSHIO SHIMOKAWA and TAROH SATOH
    Anticancer Research February 2019, 39 (2) 1059-1065; DOI: https://doi.org/10.21873/anticanres.13213
  • You have access
    Clinical Outcomes of 42 Renal Cell Carcinoma Patients With Metastases Solely to the Lung Who Received Sorafenib as Second-line Systemic Therapy
    HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA
    Anticancer Research February 2019, 39 (2) 1067-1072; DOI: https://doi.org/10.21873/anticanres.13214
  • You have access
    Influence of Postoperative Surgical Complications After Gastrectomy on Body Weight and Body Composition Changes in Patients With Gastric Cancer
    TORU AOYAMA, TAKAKI YOSHIKAWA, YUKIO MAEZAWA, KENKI SEGAMI, KAZUKI KANO, MASAKATSU NUMATA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, HIROHITO FUJIKAWA, KEISUKE KOMORI, TSUTOMU HAYASHI, TSUTOMU SATO, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA, HARUHIKO CHO and TAKASHI OSHIMA
    Anticancer Research February 2019, 39 (2) 1073-1078; DOI: https://doi.org/10.21873/anticanres.13215
  • You have access
    Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic Pattern
    SIMON GUNDÍN-MENÉNDEZ, VICTOR MOLINA SANTOS, MARINA PARRA-ROBERT, XAVIER FILELLA PLA, JOSEP M. AUGE FRADERA and RAFAEL MOLINA PORTO
    Anticancer Research February 2019, 39 (2) 1079-1083; DOI: https://doi.org/10.21873/anticanres.13216
  • You have access
    Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer
    MANABU YAMAMOTO, HIROAKI SAITO, CHIHIRO UEJIMA, AKIMITSU TANIO, YOICHIRO TADA, TOMOYUKI MATSUNAGA, TERUHISA SAKAMOTO, SOICHIRO HONJO, KEIGO ASHIDA and YOSHIYUKI FUJIWARA
    Anticancer Research February 2019, 39 (2) 1085-1090; DOI: https://doi.org/10.21873/anticanres.13217
Back to top
PreviousNext

In this issue

Anticancer Research: 39 (2)
Anticancer Research
Vol. 39, Issue 2
February 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire